Vijay Singh Deposes Mark Calcavecchia in Lawsuit Against PGA Tour

February 26, 2015

Vijay Singh has only played a handful of Champions Tour events since turning 50 in 2013, but he’s already making a name for himself on the senior circuit.

According to documents made public this week, Singh deposed two Champions Tour golfers, including 1989 British Open winner Mark Calcavecchia, in his ongoing lawsuit against the PGA Tour alleging “disparate treatment” following his admitted use of deer-antler spray, which contained IGF-1, a banned substance under the Tour’s Anti-Doping Program Manual. The PGA Tour said Singh wants to depose as many as nine more players on the senior tour even though the court’s Jan. 30 deposition deadline has passed.

In a letter submitted to Justice Eileen Bransten of the New York State Supreme Court on Tuesday, lawyers for the Tour threatened to block Singh from conducting those additional depositions.

So far, Singh has deposed 13 witnesses:

  • Six PGA Tour representatives
  • Richard Young, the lead draftsman of the World Anti-Doping Code
  • David Howman, director general of the World Anti-Doping Agency
  • Dr. Oliver Rabin, the World Anti-Doping Agency’s science director
  • Rodney McDonald, vice president of Tour Operations at Cleveland Golf, Singh’s former equipment sponsor
  • Mark Calcavecchia, who sponsored deer-antler spray until the Tour told him to stop using it in 2011
  • An unnamed Champions Tour golfer
  • An unidentified additional fact witness

According to the Tour, Singh has proposed calling an additional 11 witnesses, including nine Champions Tour golfers, Cleveland Golf president Todd Harman and Dr. Anthony Butch, the director of the UCLA Olympic Analytical Laboratory that tested the bottle of deer antler spray Singh provided to the Tour.

The PGA Tour argued that testimony from these witnesses would be irrelevant or redundant. Singh’s lawyer, Peter Ginsberg, could not be reached for comment.

For more news that golfers everywhere are talking about, follow @golf_com on Twitter, like us on Facebook, and subscribe to our YouTube video channel.